Skip to main content
Top
Published in: BMC Geriatrics 1/2023

Open Access 01-12-2023 | Dementia | Research

The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study

Authors: Edeltraut Kröger, Machelle Wilchesky, Michèle Morin, Pierre-Hugues Carmichael, Martine Marcotte, Lucie Misson, Jonathan Plante, Philippe Voyer, Pierre Durand

Published in: BMC Geriatrics | Issue 1/2023

Login to get access

Abstract

Background

Nursing home (NH) residents with severe dementia use many medications, sometimes inappropriately within a comfort care approach. Medications should be regularly reviewed and eventually deprescribed. This pragmatic, controlled trial assessed the effect of an interprofessional knowledge exchange (KE) intervention to decrease medication load and the use of medications of questionable benefit among these residents.

Methods

A 6-month intervention was performed in 4 NHs in the Quebec City area, while 3 NHs, with comparable admissions criteria, served as controls. Published lists of “mostly”, “sometimes” or “exceptionally” appropriate medications, tailored for NH residents with severe dementia, were used. The intervention included 1) information for participants’ families about medication use in severe dementia; 2) a 90-min KE session for NH nurses, pharmacists, and physicians; 3) medication reviews by NH pharmacists using the lists; 4) discussions on recommended changes with nurses and physicians. Participants’ levels of agitation and pain were evaluated using validated scales at baseline and the end of follow-up.

Results

Seven (7) NHs and 123 participants were included for study. The mean number of regular medications per participant decreased from 7.1 to 6.6 in the intervention, and from 7.7 to 5.9 in the control NHs (p-value for the difference in differences test: < 0.05). Levels of agitation decreased by 8.3% in the intervention, and by 1.4% in the control NHs (p = 0.026); pain levels decreased by 12.6% in the intervention and increased by 7% in the control NHs (p = 0.049). Proportions of participants receiving regular medications deemed only exceptionally appropriate decreased from 19 to 17% (p = 0.43) in the intervention and from 28 to 21% (p = 0.007) in the control NHs (p = 0.22). The mean numbers of regular daily antipsychotics per participant fell from 0.64 to 0.58 in the intervention and from 0.39 to 0.30 in the control NHs (p = 0.27).

Conclusions

This interprofessional intervention to reduce inappropriate medication use in NH residents with severe dementia decreased medication load in both intervention and control NHs, without important concomitant increase in agitation, but mixed effects on pain levels. Practice changes and heterogeneity within these 7 NHs, and a ceiling effect in medication optimization likely interfered with the intervention.

Trial registration

The study is registered at ClinicalTrials.gov: # NCT05155748 (first registration 03–10-2017).
Appendix
Available only for authorised users
Literature
1.
go back to reference Lopez OL, Kuller LH. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer’s disease and other dementias. Handb Clin Neurol. 2019;167:139–48.PubMed Lopez OL, Kuller LH. Epidemiology of aging and associated cognitive disorders: Prevalence and incidence of Alzheimer’s disease and other dementias. Handb Clin Neurol. 2019;167:139–48.PubMed
2.
go back to reference Helvik AS, et al. Prevalence and Severity of Dementia in Nursing Home Residents. Dement Geriatr Cogn Disord. 2015;40(3–4):166–77.PubMed Helvik AS, et al. Prevalence and Severity of Dementia in Nursing Home Residents. Dement Geriatr Cogn Disord. 2015;40(3–4):166–77.PubMed
3.
go back to reference Vossius C, et al. Mortality in nursing home residents: A longitudinal study over three years. PLoS One. 2018;13(9):e0203480.PubMedPubMedCentral Vossius C, et al. Mortality in nursing home residents: A longitudinal study over three years. PLoS One. 2018;13(9):e0203480.PubMedPubMedCentral
4.
go back to reference Kao YH, Hsu CC, Yang YH. A Nationwide Survey of Dementia Prevalence in Long-Term Care Facilities in Taiwan. J Clin Med. 2022;11(6):1554.PubMedPubMedCentral Kao YH, Hsu CC, Yang YH. A Nationwide Survey of Dementia Prevalence in Long-Term Care Facilities in Taiwan. J Clin Med. 2022;11(6):1554.PubMedPubMedCentral
5.
go back to reference Statistique Canada, Estimations de la population du Canada : âge et sexe, 1er juillet 2015, in Le Quotidien. 2015, Statistique Canada. p. 7. Statistique Canada, Estimations de la population du Canada : âge et sexe, 1er juillet 2015, in Le Quotidien. 2015, Statistique Canada. p. 7.
7.
go back to reference Holmes HM, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306–11.PubMed Holmes HM, et al. Integrating palliative medicine into the care of persons with advanced dementia: identifying appropriate medication use. J Am Geriatr Soc. 2008;56(7):1306–11.PubMed
8.
go back to reference Canadian Institute for Health Information, Drug Use Among Seniors in Canada, 2016. 2018, CIHI: Ottawa, ON. Canadian Institute for Health Information, Drug Use Among Seniors in Canada, 2016. 2018, CIHI: Ottawa, ON.
9.
go back to reference Morin L, et al. Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review. J Am Med Dir Assoc. 2016;17(9):862 e1–9.PubMed Morin L, et al. Prevalence of Potentially Inappropriate Medication Use in Older Adults Living in Nursing Homes: A Systematic Review. J Am Med Dir Assoc. 2016;17(9):862 e1–9.PubMed
10.
go back to reference Wastesson, J.A.-O., et al., How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study. (1532–5415 (Electronic)). Wastesson, J.A.-O., et al., How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study. (1532–5415 (Electronic)).
11.
go back to reference Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135(8 Pt 2):703–10.PubMed Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135(8 Pt 2):703–10.PubMed
12.
go back to reference Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4–11.PubMed Frazier SC. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005;31(9):4–11.PubMed
13.
go back to reference Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64:93–101.PubMed Khan S, Gerber DE. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review. Semin Cancer Biol. 2020;64:93–101.PubMed
14.
go back to reference Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2009;85(1):103–7.PubMed Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther. 2009;85(1):103–7.PubMed
15.
go back to reference Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15–21.PubMedPubMedCentral Maddison AR, Fisher J, Johnston G. Preventive medication use among persons with limited life expectancy. Prog Palliat Care. 2011;19(1):15–21.PubMedPubMedCentral
16.
go back to reference Blass DM, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008;23(5):490–6.PubMed Blass DM, et al. Medication use in nursing home residents with advanced dementia. Int J Geriatr Psychiatry. 2008;23(5):490–6.PubMed
17.
go back to reference Fialova D, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.PubMed Fialova D, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348–58.PubMed
18.
go back to reference Evrard P, et al. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study. J Am Geriatr Soc. 2020;68(12):2768–77.PubMed Evrard P, et al. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study. J Am Geriatr Soc. 2020;68(12):2768–77.PubMed
19.
go back to reference Stuijt CCM, et al. Appropriateness of Prescribing among Elderly Patients in a Dutch Residential Home Observational Study of Outcomes after a Pharmacist-Led Medication Review. Drugs Aging. 2008;25(11):947–54.PubMed Stuijt CCM, et al. Appropriateness of Prescribing among Elderly Patients in a Dutch Residential Home Observational Study of Outcomes after a Pharmacist-Led Medication Review. Drugs Aging. 2008;25(11):947–54.PubMed
20.
go back to reference Wright D. Medication administration in nursing homes. Nurs Stand. 2002;16(42):33–8.PubMed Wright D. Medication administration in nursing homes. Nurs Stand. 2002;16(42):33–8.PubMed
21.
go back to reference Tjia J, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880–8.PubMedPubMedCentral Tjia J, et al. Daily medication use in nursing home residents with advanced dementia. J Am Geriatr Soc. 2010;58(5):880–8.PubMedPubMedCentral
22.
go back to reference Toscani F, et al. Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. J Palliat Med. 2013;16(1):31–7.PubMed Toscani F, et al. Treatments and prescriptions in advanced dementia patients residing in long-term care institutions and at home. J Palliat Med. 2013;16(1):31–7.PubMed
23.
go back to reference Kua CH, Mak VSL, Huey Lee SW. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2019;20(3):362–372.e11.PubMed Kua CH, Mak VSL, Huey Lee SW. Health Outcomes of Deprescribing Interventions Among Older Residents in Nursing Homes: A Systematic Review and Meta-analysis. J Am Med Dir Assoc. 2019;20(3):362–372.e11.PubMed
24.
go back to reference Hashimoto R, et al. Study of pharmacist intervention in polypharmacy among older patients: Non-randomized, controlled trial. Geriatr Gerontol Int. 2020;20(3):229–37.PubMed Hashimoto R, et al. Study of pharmacist intervention in polypharmacy among older patients: Non-randomized, controlled trial. Geriatr Gerontol Int. 2020;20(3):229–37.PubMed
25.
go back to reference Balsom C, et al. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020;42(4):1153–67.PubMed Balsom C, et al. Impact of a pharmacist-administered deprescribing intervention on nursing home residents: a randomized controlled trial. Int J Clin Pharm. 2020;42(4):1153–67.PubMed
26.
go back to reference American Geriatrics Society 2019 Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;67(4):674–94. American Geriatrics Society 2019 Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015;67(4):674–94.
27.
go back to reference O’Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.PubMed O’Mahony D, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.PubMed
28.
go back to reference Arcand M, et al. Doit-on prescrire des médicaments à visée préventive dans un contexte de démence modérée ou grave? La revue de gériatrie. 2007;32(3 Mars):189–200. Arcand M, et al. Doit-on prescrire des médicaments à visée préventive dans un contexte de démence modérée ou grave? La revue de gériatrie. 2007;32(3 Mars):189–200.
29.
go back to reference Kröger E, et al. Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention. J Am Med Dir Assoc. 2015;16(7):629 e1–17.PubMed Kröger E, et al. Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention. J Am Med Dir Assoc. 2015;16(7):629 e1–17.PubMed
30.
go back to reference Wilchesky M, et al. The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study. BMC Geriatr. 2018;18(1):204.PubMedPubMedCentral Wilchesky M, et al. The OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot study. BMC Geriatr. 2018;18(1):204.PubMedPubMedCentral
31.
go back to reference Simard, M., et al., Chapitre 13 : Attitudes et comportements des aînés et de leurs proches face à la polypharmacie ou à la déprescription: une revue mixte de la littérature., in Oser les défis des méthodes mixtes en sciences sociales et sciences de la santé., Q.H. Bujold M, V Ridde, CJ Bourque, MJ Dogba, I Vedel et P Pluye., Editor. ACFAS: Montréal. Canada. 2018. 223–43. Simard, M., et al., Chapitre 13 : Attitudes et comportements des aînés et de leurs proches face à la polypharmacie ou à la déprescription: une revue mixte de la littérature., in Oser les défis des méthodes mixtes en sciences sociales et sciences de la santé., Q.H. Bujold M, V Ridde, CJ Bourque, MJ Dogba, I Vedel et P Pluye., Editor. ACFAS: Montréal. Canada. 2018. 223–43.
32.
go back to reference Armstrong R, et al. Improving the reporting of public health intervention research: advancing TREND and CONSORT. J Public Health (Oxf). 2008;30(1):103–9.PubMed Armstrong R, et al. Improving the reporting of public health intervention research: advancing TREND and CONSORT. J Public Health (Oxf). 2008;30(1):103–9.PubMed
33.
go back to reference Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361–6.PubMedPubMedCentral Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361–6.PubMedPubMedCentral
34.
go back to reference Garland CT, et al. A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care. J Am Med Dir Assoc. 2021;22(1):141–7.PubMed Garland CT, et al. A New Care Model Reduces Polypharmacy and Potentially Inappropriate Medications in Long-Term Care. J Am Med Dir Assoc. 2021;22(1):141–7.PubMed
35.
go back to reference Dubuc N, et al. Disability-based classification system for older people in integrated long-term care services: the Iso-SMAF profiles. Arch Gerontol Geriatr. 2006;42(2):191–206.PubMed Dubuc N, et al. Disability-based classification system for older people in integrated long-term care services: the Iso-SMAF profiles. Arch Gerontol Geriatr. 2006;42(2):191–206.PubMed
36.
go back to reference World Health Organization. International Classification of Impairments, Disabilities, and Handicaps: A Manual of Classification Relating to the Consequences of Disease. Geneva: WHO; 1980. World Health Organization. International Classification of Impairments, Disabilities, and Handicaps: A Manual of Classification Relating to the Consequences of Disease. Geneva: WHO; 1980.
37.
go back to reference Reisberg B, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.PubMed Reisberg B, et al. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139(9):1136–9.PubMed
38.
go back to reference Mallery LH, et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. J Am Med Dir Assoc. 2013;14(11):801–8.PubMed Mallery LH, et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: from the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. J Am Med Dir Assoc. 2013;14(11):801–8.PubMed
39.
go back to reference Mallery LH, et al. Promoting higher blood pressure targets for frail older adults: A consensus guideline from Canada. Cleve Clin J Med. 2014;81(7):427–37.PubMed Mallery LH, et al. Promoting higher blood pressure targets for frail older adults: A consensus guideline from Canada. Cleve Clin J Med. 2014;81(7):427–37.PubMed
40.
go back to reference Smith AJ, Tett SE. Improving the use of benzodiazepines–is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res. 2010;10(321):321.PubMedPubMedCentral Smith AJ, Tett SE. Improving the use of benzodiazepines–is it possible? A non-systematic review of interventions tried in the last 20 years. BMC Health Serv Res. 2010;10(321):321.PubMedPubMedCentral
41.
go back to reference Tjia J, et al. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095–101.PubMedPubMedCentral Tjia J, et al. Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc. 2014;62(11):2095–101.PubMedPubMedCentral
42.
go back to reference Ballard C, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5(4):587–99. Ballard C, et al. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5(4):587–99.
43.
go back to reference Tjia J, et al. The Impact of a Communication-Training Program on Reductions in Nursing Home Antipsychotic Use. Pharmacoepidemiol Drug Saf. 2015;24(September S1):33–4. Tjia J, et al. The Impact of a Communication-Training Program on Reductions in Nursing Home Antipsychotic Use. Pharmacoepidemiol Drug Saf. 2015;24(September S1):33–4.
44.
go back to reference Tjia J, et al. Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia. Consult Pharm. 2015;30(10):599–611.PubMedPubMedCentral Tjia J, et al. Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia. Consult Pharm. 2015;30(10):599–611.PubMedPubMedCentral
45.
go back to reference McCabe MP, et al. An RCT to evaluate the utility of a clinical protocol for staff in the management of behavioral and psychological symptoms of dementia in residential aged-care settings. Aging Ment Health. 2015;19(9):799–807.PubMed McCabe MP, et al. An RCT to evaluate the utility of a clinical protocol for staff in the management of behavioral and psychological symptoms of dementia in residential aged-care settings. Aging Ment Health. 2015;19(9):799–807.PubMed
46.
go back to reference Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). Pain Manag Nurs. 2004;5(1):37–49.PubMed Fuchs-Lacelle S, Hadjistavropoulos T. Development and preliminary validation of the pain assessment checklist for seniors with limited ability to communicate (PACSLAC). Pain Manag Nurs. 2004;5(1):37–49.PubMed
47.
go back to reference Aubin M, et al. Validity “and Utilities” clinic of a grid observation (PACSLAC-F) to evaluate the pain in seniors with dementia’s living in the Long-Term Care. Can J Aging. 2008;27(1):45–55.PubMed Aubin M, et al. Validity “and Utilities” clinic of a grid observation (PACSLAC-F) to evaluate the pain in seniors with dementia’s living in the Long-Term Care. Can J Aging. 2008;27(1):45–55.PubMed
48.
go back to reference Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77–84.PubMed Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989;44(3):M77–84.PubMed
49.
go back to reference McCoy CE. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West J Emerg Med. 2017;18(6):1075–8.PubMedPubMedCentral McCoy CE. Understanding the Intention-to-treat Principle in Randomized Controlled Trials. West J Emerg Med. 2017;18(6):1075–8.PubMedPubMedCentral
50.
go back to reference Eichinger M, et al. Evaluating the Public Climate School-A School-Based Programme to Promote Climate Awareness and Action in Students: Protocol of a Cluster-Controlled Pilot Study. Int J Environ Res Public Health. 2022;19(13):8039.PubMedPubMedCentral Eichinger M, et al. Evaluating the Public Climate School-A School-Based Programme to Promote Climate Awareness and Action in Students: Protocol of a Cluster-Controlled Pilot Study. Int J Environ Res Public Health. 2022;19(13):8039.PubMedPubMedCentral
52.
go back to reference Cossette B, et al. Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices. J Am Med Dir Assoc. 2020;21(2):212–9.PubMed Cossette B, et al. Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices. J Am Med Dir Assoc. 2020;21(2):212–9.PubMed
53.
go back to reference Bjerre LM, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia (BPSD) and insomnia: an evidence-based clinical practice guideline. 2015. Bjerre LM, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia (BPSD) and insomnia: an evidence-based clinical practice guideline. 2015.
54.
go back to reference Campitelli MA, et al. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021;4(8):e2118441.PubMedPubMedCentral Campitelli MA, et al. Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021;4(8):e2118441.PubMedPubMedCentral
55.
go back to reference Mühlbauer V, et al. Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev. 2021;12(12):Cd013304.PubMed Mühlbauer V, et al. Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia. Cochrane Database Syst Rev. 2021;12(12):Cd013304.PubMed
56.
go back to reference Verreault R, et al. Quasi-experimental evaluation of a multifaceted intervention to improve quality of end-of-life care and quality of dying for patients with advanced dementia in long-term care institutions. Palliat Med. 2018;32(3):613–21.PubMed Verreault R, et al. Quasi-experimental evaluation of a multifaceted intervention to improve quality of end-of-life care and quality of dying for patients with advanced dementia in long-term care institutions. Palliat Med. 2018;32(3):613–21.PubMed
57.
go back to reference Calcaterra L, et al. Predictors of drug prescription in nursing home residents: results from the INCUR study. Intern Emerg Med. 2022;17(1):165–71.PubMed Calcaterra L, et al. Predictors of drug prescription in nursing home residents: results from the INCUR study. Intern Emerg Med. 2022;17(1):165–71.PubMed
58.
go back to reference Halvorsen KH, et al. Assessing Potentially Inappropriate Medications in Nursing Home Residents by NORGEP-NH Criteria. Pharmacy (Basel, Switzerland). 2019;7(1):26.PubMed Halvorsen KH, et al. Assessing Potentially Inappropriate Medications in Nursing Home Residents by NORGEP-NH Criteria. Pharmacy (Basel, Switzerland). 2019;7(1):26.PubMed
59.
go back to reference Holmes HM, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013;30(9):655–66.PubMedPubMedCentral Holmes HM, et al. Rationalizing prescribing for older patients with multimorbidity: considering time to benefit. Drugs Aging. 2013;30(9):655–66.PubMedPubMedCentral
60.
go back to reference Arcand M, et al. Educating families about end-of-life care in advanced dementia: acceptability of a Canadian family booklet to nurses from Canada, France, and Japan. Int J Palliat Nurs. 2013;19(2):67–74.PubMed Arcand M, et al. Educating families about end-of-life care in advanced dementia: acceptability of a Canadian family booklet to nurses from Canada, France, and Japan. Int J Palliat Nurs. 2013;19(2):67–74.PubMed
61.
go back to reference Arcand M, et al. Educating nursing home staff about the progression of dementia and the comfort care option: impact on family satisfaction with end-of-life care. J Am Med Dir Assoc. 2009;10(1):50–5.PubMed Arcand M, et al. Educating nursing home staff about the progression of dementia and the comfort care option: impact on family satisfaction with end-of-life care. J Am Med Dir Assoc. 2009;10(1):50–5.PubMed
62.
go back to reference Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.PubMedPubMedCentral Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ. 2015;350:h369.PubMedPubMedCentral
63.
go back to reference Ballard CG, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.PubMed Ballard CG, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol. 2009;5(5):245–55.PubMed
64.
go back to reference Gill SS, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775–86.PubMed Gill SS, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775–86.PubMed
65.
go back to reference Rochon PA, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008;168(10):1090–6.PubMed Rochon PA, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med. 2008;168(10):1090–6.PubMed
67.
go back to reference Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6(6):212–33.PubMedPubMedCentral Garfinkel D, Ilhan B, Bahat G. Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf. 2015;6(6):212–33.PubMedPubMedCentral
68.
go back to reference Wouters H, et al. Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial. BMJ Open. 2014;4(10):e006082.PubMedPubMedCentral Wouters H, et al. Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial. BMJ Open. 2014;4(10):e006082.PubMedPubMedCentral
69.
go back to reference Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.PubMed Gallagher P, O’Mahony D. STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers’ criteria. Age Ageing. 2008;37(6):673–9.PubMed
Metadata
Title
The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study
Authors
Edeltraut Kröger
Machelle Wilchesky
Michèle Morin
Pierre-Hugues Carmichael
Martine Marcotte
Lucie Misson
Jonathan Plante
Philippe Voyer
Pierre Durand
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2023
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04222-4

Other articles of this Issue 1/2023

BMC Geriatrics 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine